文献速递胸部介入CT

比较经皮微波消融与冷冻消融肺部肿瘤后预期影像学表现:消融区与胸部淋巴结

Comparison of expected imaging findings following percutaneous microwave and cryoablation of pulmonary tumors: ablation zones and thoracic lymph nodes.
PubMed 文献 · Eur Radiol · 2022-06-15

该回顾性队列研究比较了2006-2020年间肺微波消融(MWA)与冷冻消融后消融区和胸部淋巴结的时间变化。消融区体积缩小至75%的时间在两种方法间无差异;MWA后胸部淋巴结出现一过性增大,而冷冻消融后未观察到淋巴结变化。

要点

  • MWA与冷冻消融后消融区体积缩小至75%的时间无显著差异。
  • MWA后胸部淋巴结可出现一过性增大,6个月内缩小,不代表肿瘤播散。
  • 冷冻消融后未观察到胸部淋巴结显著增大。

核心结论

  • MWA与冷冻消融的消融区体积缩小速率无差异;MWA后胸部淋巴结出现一过性增大,而冷冻消融后未出现。

研究设计与样本

  • 回顾性队列研究,比较2006-2020年肺MWA与冷冻消融;消融区队列在12个月内系列CT测量体积;淋巴结队列在基线至术后6个月测量淋巴结双径乘积之和;采用累积发病率曲线和线性混合效应模型分析。

关键影像表现/征象

  • 消融区体积缩小至75%的估计时间:MWA为340天,冷冻消融为214天(p = .30),差异未达统计学显著。
  • MWA后胸部淋巴结从基线至32天平均增大38 mm2(95%CI, 5.0-70.7; p = .02),随后32-123天估计缩小50 mm2(p = .001)。
  • 冷冻消融后胸部淋巴结变化未检测到(基线至32天,p = .33)。
  • MWA与冷冻消融后胸部淋巴结大小在基线-32天(p = .01)和32-123天(p = .001)存在差异。

临床应用与阅片要点

  • MWA后胸部淋巴结一过性增大可能为预期反应,并非肿瘤区域播散,6个月内可缩小。
  • 冷冻消融后胸部淋巴结增大未见报告,若出现需结合临床判断。
  • 消融区体积缩小至75%的时间在两种方法间无显著差异,随访影像评估可参考此时间范围。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To compare temporal changes of ablation zones and lymph nodes following lung microwave ablation (MWA) and cryoablation.

METHODS: This retrospective cohort study compared lung ablation zones and thoracic lymph nodes following MWA and cryoablation performed 2006-2020. In the ablation zone cohort, ablation zone volumes were measured on serial CT for 12 months. In the lymph node cohort, the sum of bidimensional products of lymph node diameters was measured before (baseline) and up to 6 months following ablation. Cumulative incidence curves estimated the time to 75% ablation zone reduction and linear mixed-effects regression models compared the temporal distribution of ablation zones and lymph node sizes between modalities.

RESULTS: Ablation zones of 59 tumors treated in 45 sessions (16 MWA, 29 cryoablation) in 36 patients were evaluated. Differences in the time to 75% volume reduction between modalities were not detected. Following MWA, half of the ablation zones required an estimated time of 340 days to achieve a 75% volume reduction compared to 214 days following cryoablation (p = .30). Thoracic lymph node sizes after 33 sessions (13 MWA, 20 cryoablation) differed between modalities (baseline-32 days, p = .01; 32-123 days, p = .001). Following MWA, lymph nodes increased on average by 38 mm2 (95%CI, 5.0-70.7; p = .02) from baseline to 32 days, followed by an estimated decrease of 50 mm2 (32-123 days; p = .001). Following cryoablation, changes in lymph nodes were not detected (baseline-32 days, p = .33).

CONCLUSION: The rate of ablation zone volume reduction did not differ between MWA and cryoablation. Thoracic lymph nodes enlarged transiently after MWA but not after cryoablation.

KEY POINTS: • Contrary to current belief, the rate of lung ablation zone volume reduction did not differ between microwave and cryoablation. • Transient enlargement of thoracic lymph nodes after microwave ablation was not associated with regional tumor spread and decreased within six months following ablation. • No significant thoracic lymph node enlargement was observed following cryoablation.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Wrobel, Cahalane, Pachamanova, et al. Comparison of expected imaging findings following percutaneous microwave and cryoablation of pulmonary tumors: ablation zones and thoracic lymph nodes. Eur Radiol. 2022. PMID: 35704108. doi:10.1007/s00330-022-08905-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。